- Home
- JLL vs ICLR Comparison
JLL vs ICLR Comparison
Compare JLL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JLL | ICLR |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | United States | Ireland |
| Employees | 48000 | N/A |
| Industry | Real Estate | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 13.1B |
| IPO Year | 1997 | 2001 |
Fundamental Metrics
Financial Performance| Metric | JLL | ICLR |
|---|---|---|
| Price | $300.87 | $183.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | ★ $406.80 | $188.24 |
| AVG Volume (30 Days) | 421.7K | ★ 822.2K |
| Earning Date | 10-28-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.13 | N/A |
| EPS | ★ 7.91 | N/A |
| Revenue | ★ $26,115,600,000.00 | N/A |
| Revenue This Year | $11.16 | N/A |
| Revenue Next Year | $7.83 | $3.39 |
| P/E Ratio | $37.97 | ★ $12.91 |
| Revenue Growth | ★ 11.45 | N/A |
| 52 Week Low | $259.83 | $66.57 |
| 52 Week High | $393.84 | $203.91 |
Technical Indicators
Market Signals| Indicator | JLL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 62.89 |
| Support Level | $284.05 | $157.92 |
| Resistance Level | $312.95 | $191.00 |
| Average True Range (ATR) | 9.95 | 7.99 |
| MACD | 1.94 | 2.07 |
| Stochastic Oscillator | 48.75 | 78.98 |
Price Performance
Historical ComparisonAbout JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle is a global commercial real estate services and investment management company that helps clients buy, build, occupy, manage, and invest in property across office, industrial, retail, multifamily, hotel, and data center assets. For over 200 years, clients have trusted JLL, a Fortune 500 company, tracing its roots to firms including LaSalle Partners (founded in Chicago in 1968) and the centuries-old London firm Jones Lang Wootton, which merged in 1999 to form the modern JLL. Today, the firm is a leading global commercial real estate services and investment management company with operations in over 80 countries and a global workforce of more than 113,000, as of early 2026.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.